TEE
VBIV

Tibra Equities Europe’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Tibra Equities Europe’s Portfolio VBIV Stock Details VBIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-3,753
Closed -$211K – 462
2019
Q1 		$211K Buy
+3,753
New +$203K 0.02% 369

Other funds holding VBIV

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
GAI
General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return

Tibra Equities Europe's VBIV Position: Q2 2019 in Review

Tibra Equities Europe sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q2 2019, closing a stake of 3,753 shares — an estimated $211K sold.

Tibra Equities Europe first reported a position in VBIV in Q1 2019 and held it in 1 quarter. The position peaked at $211K in Q1 2019. 56 funds tracked by Wall St. Rank hold VBIV as of Q2 2019.

  • Tibra Equities Europe reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q2 2019 after selling out during the quarter.
  • Tibra Equities Europe sold 3,753 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q2 2019, an estimated $211K.
  • Tibra Equities Europe first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q1 2019 and held it in 1 quarter.
  • Tibra Equities Europe's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $211K in Q1 2019.
  • 56 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q2 2019.

Based on Tibra Equities Europe's 13F filing for Q2 2019, filed 1 Aug 2019.